secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2023-01-24T23:59:59+00:00
Accession:  0001575872-23-000129
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TradeUP Acquisition extends business combination deadline to Feb 19, 2023; issues notes for extension expenses
--------------------------------------------------------------------------------

- Deposited $45,511 into trust to extend deadline from Jan 19 to Feb 19, 2023, funded by Estrella Biopharma.
- Issued unsecured $45,511 promissory note to Estrella for extension deposit; no interest, due at merger close.
- Issued $50,000 promissory note to sponsor TradeUP Acquisition Sponsor LLC for operating expenses, convertible at $10/share.
- Company may extend monthly until July 19, 2023 by depositing additional $45,511 each month.
- Notes convertible into common stock at $10 per share upon written notice two business days before merger close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223000129/0001575872-23-000129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223000129/uptd-20230131.htm
  HTML page:      https://secwatch.observer/filing/0001575872-23-000129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer